chr3-8985783-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_014850.4(SRGAP3):c.3036C>T(p.Pro1012=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00153 in 1,600,284 control chromosomes in the GnomAD database, including 29 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0080 ( 15 hom., cov: 31)
Exomes 𝑓: 0.00085 ( 14 hom. )
Consequence
SRGAP3
NM_014850.4 synonymous
NM_014850.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.949
Genes affected
SRGAP3 (HGNC:19744): (SLIT-ROBO Rho GTPase activating protein 3) Predicted to enable GTPase activator activity. Predicted to be involved in negative regulation of cell migration. Predicted to be located in cytosol. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.51).
BP6
Variant 3-8985783-G-A is Benign according to our data. Variant chr3-8985783-G-A is described in ClinVar as [Benign]. Clinvar id is 782421.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.949 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00798 (1214/152194) while in subpopulation AFR AF= 0.027 (1122/41532). AF 95% confidence interval is 0.0257. There are 15 homozygotes in gnomad4. There are 561 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1214 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SRGAP3 | NM_014850.4 | c.3036C>T | p.Pro1012= | synonymous_variant | 22/22 | ENST00000383836.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SRGAP3 | ENST00000383836.8 | c.3036C>T | p.Pro1012= | synonymous_variant | 22/22 | 1 | NM_014850.4 | P1 | |
SRGAP3 | ENST00000360413.7 | c.2964C>T | p.Pro988= | synonymous_variant | 22/22 | 1 |
Frequencies
GnomAD3 genomes AF: 0.00797 AC: 1212AN: 152078Hom.: 15 Cov.: 31
GnomAD3 genomes
AF:
AC:
1212
AN:
152078
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00214 AC: 509AN: 237400Hom.: 6 AF XY: 0.00153 AC XY: 198AN XY: 129514
GnomAD3 exomes
AF:
AC:
509
AN:
237400
Hom.:
AF XY:
AC XY:
198
AN XY:
129514
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000849 AC: 1229AN: 1448090Hom.: 14 Cov.: 31 AF XY: 0.000766 AC XY: 552AN XY: 720846
GnomAD4 exome
AF:
AC:
1229
AN:
1448090
Hom.:
Cov.:
31
AF XY:
AC XY:
552
AN XY:
720846
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00798 AC: 1214AN: 152194Hom.: 15 Cov.: 31 AF XY: 0.00754 AC XY: 561AN XY: 74396
GnomAD4 genome
AF:
AC:
1214
AN:
152194
Hom.:
Cov.:
31
AF XY:
AC XY:
561
AN XY:
74396
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
4
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
SRGAP3-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 06, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at